SCHEMBL5423536

SCHEMBL5423536

Cc1cccc2c1N(C1CCN(S(=O)(=O)c3cccc(Br)c3)CC1)COC2

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MBTD1 Q05BQ5 1/20 0.54
L3MBTL3 Q96JM7 1/20 0.54
HTR6 P50406 5/20 0.43
ALDH1A1 P00352 5/20 0.42
HPGD P15428 1/20 0.42
TDP1 Q9NUW8 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
LMNA P02545 3/20 0.38
POLB P06746 2/20 0.38
TSHR P16473 2/20 0.38
HTT P42858 2/20 0.38
MAPT P10636 2/20 0.38
GAA P10253 1/20 0.38
CYP3A4 P08684 1/20 0.38
GRM5 P41594 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
TP53 P04637 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5421824 0.90 HTR6 (0.44) MBTD1L3MBTL3HTR6ALDH1A1TDP1
SCHEMBL5780968 0.88 HTR6 (0.52) MBTD1L3MBTL3HTR6
SCHEMBL5421820 0.88 SMN1; SMN2 (0.46) HTR6ALDH1A1HPGDTDP1MEN1
SCHEMBL5426227 0.88 ALDH1A1 (0.47) MBTD1L3MBTL3HTR6ALDH1A1HPGD
SCHEMBL5426036 0.85 LMNA (0.51) HTR6ALDH1A1MEN1KMT2ALMNA
SCHEMBL5439699 0.84 ALDH1A1 (0.55) HTR6ALDH1A1TDP1MEN1KMT2A
SCHEMBL5430905 0.84 PKM (0.50) HTR6ALDH1A1TDP1MEN1KMT2A
SCHEMBL5421773 0.83 MBTD1 (0.53) MBTD1L3MBTL3ALDH1A1HPGDMEN1
SCHEMBL5428892 0.83 HTR6 (0.52) HTR6ALDH1A1HPGDTDP1LMNA
SCHEMBL5434962 0.82 MBTD1 (0.57) MBTD1L3MBTL3ALDH1A1HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070032482-A1 Benzoxazinone-derived sulfonamide compounds, their preparation and use as medicaments LABORATORIOS DEL DR. ESTEVE S.A. (ES) 2007-02-08 US claimed
US-20070032482-A1 Benzoxazinone-derived sulfonamide compounds, their preparation and use as medicaments LABORATORIOS DEL DR. ESTEVE S.A. (ES) 2007-02-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070032482-A1 Benzoxazinone-derived sulfonamide compounds, their preparation and use as medicaments HTR6, HTR5A, P2RX6 MBTD1 1365/4885L3MBTL3 4883/4885HTR6 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.